Phase
Condition
Mild Cognitive Impairment
Dementia
Mental Disability
Treatment
Treatment-as-usual
MindAhead Active
Clinical Study ID
Ages > 50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of cognitive impairment in MCI stage (ICD-10 codes: F06.7, F07.8) or milddementia stage (ICD-10: F00.-*, F01.-, F03) due to all etiologies apart frometiologies described in F02.- (Pick's disease, Parkinson's disease, multiplesclerosis, Huntington's disease, HIV, Lewy body disease). Hence, etiologies of MCIand mild dementia include
Alzheimer's disease (e.g., F00.-*)
Vascular disease (e.g., F01.-) (exception in case of stroke: event occurred > 12 months ago without ongoing spontaneous remission)
Mixed diseases
Unclear etiologies
MCI or mild dementia diagnosis assigned within the last 12 months by a neurologistor psychiatrist from our cooperation partners that fulfil adequate diagnosisprocedures such as neuropsychological assessment, brain imaging, self- and/orthird-party medical history interview, and potentially cerebrospinal fluid, positronemission tomography, or electrophysiological measures
MCI or mild dementia diagnosis confirmed by a treating physician
MMSE ≥ 24 or MoCA ≥ 18 (last date of assessment is decisive; needs to be within thelast 12 months)
Sufficient physical fitness to engage in physical activities (e.g., walking orcycling) as confirmed by a treating physician
Age ≥ 50
German language skills sufficient to understand German instructions of studyassessments and of the intervention
Ability and sufficient vision to operate a smartphone
Exclusion
Exclusion Criteria:
possibly moderate or severe cognitive impairment (moderate or severe dementia),indicated by MMSE < 24 or MoCA < 18 (last date of assessment is decisive; needs tobe within the last 12 months)
Specific brain injury events within the last 12 months or with ongoing spontaneousremission due to
Stroke (ischemic, hemorrhagic)
Traumatic brain injury
Specific etiologies of MCI or mild dementia (F02.-) that show a variable course or afast progression including
Multiple sclerosis
Parkinson's disease
Pick's disease / Frontotemporal lobar degeneration
Lewy body disease
Brain tumors
Autosomal dominant form of Alzheimer's disease with early first manifestation
Creutzfeldt-Jakob disease
German language restrictions or visual restrictions which prevent from understandingwritten German instructions of assessment or intervention procedures (e.g. severeaphasia, lack of sufficient German language skills, severe non-corrected visualimpairment)
Study Design
Study Description
Connect with a study center
University Medical Center Göttingen
Göttingen,
GermanySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.